MAPT and Alzheimer disease: Longitudinal multimodal analyses revealed that men showed greater sensitivity to structural neuroimaging and CSF biomarkers—particularly hippocampal volume and tau/Aβ ratios—relative to women during the MCI to AD progression (Sarica et al., 2024).